期刊
MICROBES AND INFECTION
卷 20, 期 4, 页码 222-227出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.micinf.2018.02.005
关键词
Metagenomics; Next-generation sequencing; Microbiota; Bioinformatics; Conference report
资金
- American Society of Microbiology [ASM]
- Campus Biotech Foundation
- Federation of European Microbiology Societies [FEMS]
- Geneva University Hospitals [HUG]
- Swiss National Fund [31CO30_175439]
- Becton-Dickinson
- Danone
- Ofxord Nanopore Technologies
- Roche
- bioMerieux
- Fasteris
- Ferring
- Institut Merieux
- MaaT Pharma
- Nestle
- Pathoquest
Clinical metagenomics (CMg) refers to as the application of metagenomic sequencing of clinical samples in order to recover clinically-relevant information. Due to the increasing access to next-generation sequencing (NGS) facilities, CMg is a gast-growing field. In this context, we held the second International Conference on Clinical Metagenomics (ICCMg2) in Geneva in October 2017. During the two days of the conference, several aspects of CMg were addressed, which we propose to summarize in the present manuscript. Besides, we also discuss the evolution of CMg from the last conference held in 2016. In brief, many technical issues related to CMg are expected to be successfully addressed in the coming years. Conversely, assessing the clinical value of CMg, implementing a quality process, storage of data and the ethics of CMg are emerging challenges. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据